Adverse cardiovascular, limb, and renal outcomes in patients with diabetes after peripheral artery disease revascularization treated with sodium glucose cotransporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitors

AIMS: The effectiveness and limb safety of sodium glucose co-transporter 2 inhibitors (SGLT2i) for patients with type-2 diabetes (T2D) who have received peripheral artery disease (PAD) revascularization are unknown. METHODS AND RESULTS: In this nationwide retrospective cohort study, we identified a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hsin-Fu, Chuang, Chi, Li, Pei-Ru, Yeh, Yung-Hsin, Chan, Yi-Hsin, See, Lai-Chu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847141/
https://www.ncbi.nlm.nih.gov/pubmed/36653811
http://dx.doi.org/10.1186/s13098-023-00982-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847141/
https://www.ncbi.nlm.nih.gov/pubmed/36653811
http://dx.doi.org/10.1186/s13098-023-00982-6

Ejemplares similares